Tsivia Hochman

2.5k total citations
45 papers, 1.9k citations indexed

About

Tsivia Hochman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Tsivia Hochman has authored 45 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Tsivia Hochman's work include Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Tsivia Hochman is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Tsivia Hochman collaborates with scholars based in United States, France and Vietnam. Tsivia Hochman's co-authors include Judith D. Goldberg, Silvia C. Formenti, Robert J. Schneider, Rezina Arju, R. Sean Morrison, Carolyn W. Zhu, Joan D. Penrod, Evelyn Granieri, Carol Luhrs and Farbod Darvishian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular Cell.

In The Last Decade

Tsivia Hochman

43 papers receiving 1.9k citations

Peers

Tsivia Hochman
Rajen Mody United States
Terry A. Vik United States
Vanesa Bijol United States
Christine Hartford United States
Yoshihiro Yonekawa United States
M. Bacchi Switzerland
Imad A. Tabbara United States
Rajen Mody United States
Tsivia Hochman
Citations per year, relative to Tsivia Hochman Tsivia Hochman (= 1×) peers Rajen Mody

Countries citing papers authored by Tsivia Hochman

Since Specialization
Citations

This map shows the geographic impact of Tsivia Hochman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsivia Hochman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsivia Hochman more than expected).

Fields of papers citing papers by Tsivia Hochman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsivia Hochman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsivia Hochman. The network helps show where Tsivia Hochman may publish in the future.

Co-authorship network of co-authors of Tsivia Hochman

This figure shows the co-authorship network connecting the top 25 collaborators of Tsivia Hochman. A scholar is included among the top collaborators of Tsivia Hochman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsivia Hochman. Tsivia Hochman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Deirdre Jill, Judith D. Goldberg, Lawrence P. Leichman, et al.. (2024). Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: An AGICC clinical trial.. Journal of Clinical Oncology. 42(16_suppl). 4175–4175. 1 indexed citations
3.
Butler, Tracy, Judith D. Goldberg, James E. Galvin, et al.. (2021). Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's. Contemporary Clinical Trials. 107. 106488–106488. 13 indexed citations
4.
Novik, Yelena, Maryann Kwa, James L. Speyer, et al.. (2020). 129P Phase II study of pembrolizumab and nab-paclitaxel in HER2-negative metastatic breast cancer: Hormone receptor-positive cohort. Annals of Oncology. 31. S59–S59. 2 indexed citations
5.
Hochman, Tsivia, Benjamin T. Cooper, Moses Tam, et al.. (2018). Hypofractionated Whole-Breast Irradiation in Women Less Than 50 Years Old Treated on 4 Prospective Protocols. International Journal of Radiation Oncology*Biology*Physics. 101(5). 1159–1167. 10 indexed citations
6.
Goldberg, Judith D., Tsivia Hochman, Benjamin Levinson, et al.. (2017). Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City. Cancer Causes & Control. 29(2). 253–260. 1 indexed citations
7.
Mascarenhas, John, Lonette Sandy, Min Lü, et al.. (2016). A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF). Leukemia Research. 53. 13–19. 38 indexed citations
8.
Roy, Debasmita, David Michaelson, Tsivia Hochman, et al.. (2015). Cell cycle features of C. elegans germline stem/progenitor cells vary temporally and spatially. Developmental Biology. 409(1). 261–271. 28 indexed citations
9.
Wengrod, Jordan, Eleazar Vega‐Saenz de Miera, Ding Wang, et al.. (2013). PP6C Hotspot Mutations in Melanoma Display Sensitivity to Aurora Kinase Inhibition. Molecular Cancer Research. 12(3). 433–439. 30 indexed citations
10.
Karajannis, Matthias A., Geneviève Legault, Mari Hagiwara, et al.. (2013). Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro-Oncology. 16(2). 292–297. 80 indexed citations
11.
Mascarenhas, John, Min Lü, Timmy Li, et al.. (2013). A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post‐polycythaemia vera/essential thrombocythaemia myelofibrosis (post‐PV/ET MF). British Journal of Haematology. 161(1). 68–75. 66 indexed citations
12.
Adams, Sylvia, Lina Kozhaya, Frank Martiniuk, et al.. (2012). Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer. Clinical Cancer Research. 18(24). 6748–6757. 184 indexed citations
13.
Lymberis, Stella, J. Keith DeWyngaert, Preeti K. Parhar, et al.. (2012). Prospective Assessment of Optimal Individual Position (Prone Versus Supine) for Breast Radiotherapy: Volumetric and Dosimetric Correlations in 100 Patients. International Journal of Radiation Oncology*Biology*Physics. 84(4). 902–909. 104 indexed citations
14.
Weinstock, Chana, et al.. (2012). Outcomes of Surveillance for Contralateral Breast Cancer in Patients Less than Age 60 at the Time of Initial Diagnosis. Current Oncology. 19(3). 160–164. 7 indexed citations
15.
Malik, Rena D., Judith D. Goldberg, Tsivia Hochman, & Herbert Lepor. (2011). Three-Year Postoperative Ultrasensitive Prostate-Specific Antigen Following Open Radical Retropubic Prostatectomy Is a Predictor for Delayed Biochemical Recurrence. European Urology. 60(3). 548–553. 17 indexed citations
16.
Simpson, Natalie E., W. Marcus Lambert, Shah Giashuddin, et al.. (2010). High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance. Cancer Research. 70(21). 8446–8456. 48 indexed citations
17.
Adams, Sylvia, A. Bapsi Chakravarthy, Martin Donach, et al.. (2010). Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival. Breast Cancer Research and Treatment. 124(3). 723–732. 63 indexed citations
18.
Cremer, Miriam, et al.. (2009). HPV Vaccine Acceptability by Latino Parents: A Comparison of U.S. and Salvadoran Populations. Journal of Pediatric and Adolescent Gynecology. 22(4). 205–215. 32 indexed citations
19.
Silvera, Deborah, Rezina Arju, Farbod Darvishian, et al.. (2009). Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nature Cell Biology. 11(7). 903–908. 192 indexed citations
20.
Penrod, Joan D., et al.. (2006). Brief report: β-blocker use among veterans with systolic heart failure. Journal of General Internal Medicine. 21(12). 1306–1309. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026